Physician profile
Marianne Mitchell
NPI 1326152844
$733.04
in general payments reported to CMS, 2019-2025
10 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $71.93 · 2023: $313 · 2024: $230 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661 · Education: $0.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.76 |
| Education | $0.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $275.49 | 2022-2025 | Tezspire, Airsupra, Breztri |
| Genzyme Corporation | $172.90 | 2023-2024 | |
| Glaxosmithkline, LLC. | $65.52 | 2022-2023 | Nucala |
| Pfizer INC. | $59.79 | 2022-2024 | |
| Insmed, INC. | $33.49 | 2022-2025 | Arikayce |
| Abbvie INC. | $30.80 | 2025 | |
| Harmony Biosciences LLC | $27.52 | 2023 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $24.72 | 2025 | Glassia |
| Mylan Specialty L.P. | $23.98 | 2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $18.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.